Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke

Chung Yang Yeh, Ashlyn M. Bulas, Aubin Moutal, Jami L. Saloman, Karen A. Hartnett, Charles T. Anderson, Thanos Tzounopoulos, Dandan Sun, Rajesh Khanna, Elias Aizenman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The voltage-gated K+ channel Kv2.1 has been intimately linked with neuronal apoptosis. After ischemic, oxidative, or inflammatory insults, Kv2.1 mediates a pronounced, delayed enhancement of K+ efflux, generating an optimal intracellular environment for caspase and nuclease activity, key components of programmed cell death. This apoptosis-enabling mechanism is initiated via Zn2--dependent dual phosphorylation of Kv2.1, increasing the interaction between the channel’s intracellular C-terminus domain and the SNARE(soluble N-ethylmaleimide-sensitive factor activating protein receptor) protein syntaxin 1A. Subsequently, an upregulation of de novo channel insertion into the plasma membrane leads to the critical enhancement of K+ efflux in damaged neurons. Here, we investigated whether a strategy designed to interfere with the cell death-facilitating properties of Kv2.1, specifically its interaction with syntaxin 1A, could lead to neuroprotection following ischemic injury in vivo. The minimal syntaxin 1A-binding sequence of Kv2.1 C terminus (C1aB) was first identified via a far-Western peptide screen and used to create a protherapeutic product by conjugating C1aB to a cell-penetrating domain. The resulting peptide (TAT-C1aB) suppressed enhanced whole-cell K+ currents produced by a mutated form of Kv2.1 mimicking apoptosis in a mammalian expression system, and protected cortical neurons from slow excitotoxic injury in vitro, without influencing NMDA-induced intracellular calcium responses. Importantly, intraperitoneal administration of TAT-C1aB in mice following transient middle cerebral artery occlusion significantly reduced ischemic stroke damage and improved neurological outcome. These results provide strong evidence that targeting the proapoptotic function of Kv2.1 is an effective and highly promising neuroprotective strategy.

Original languageEnglish (US)
Pages (from-to)5648-5658
Number of pages11
JournalJournal of Neuroscience
Volume37
Issue number23
DOIs
StatePublished - Jun 7 2017

Fingerprint

Syntaxin 1
Qa-SNARE Proteins
Potassium Channels
Cell Death
Stroke
Apoptosis
N-Ethylmaleimide-Sensitive Proteins
Voltage-Gated Potassium Channels
Neurons
SNARE Proteins
Peptides
Middle Cerebral Artery Infarction
Wounds and Injuries
N-Methylaspartate
Caspases
Up-Regulation
Phosphorylation
Cell Membrane
Calcium
Proteins

Keywords

  • Apoptosis
  • Ischemia
  • Neuroprotection
  • Potassium channel
  • Syntaxin
  • Zinc

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Yeh, C. Y., Bulas, A. M., Moutal, A., Saloman, J. L., Hartnett, K. A., Anderson, C. T., ... Aizenman, E. (2017). Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke. Journal of Neuroscience, 37(23), 5648-5658. https://doi.org/10.1523/JNEUROSCI.3811-16.2017

Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke. / Yeh, Chung Yang; Bulas, Ashlyn M.; Moutal, Aubin; Saloman, Jami L.; Hartnett, Karen A.; Anderson, Charles T.; Tzounopoulos, Thanos; Sun, Dandan; Khanna, Rajesh; Aizenman, Elias.

In: Journal of Neuroscience, Vol. 37, No. 23, 07.06.2017, p. 5648-5658.

Research output: Contribution to journalArticle

Yeh, CY, Bulas, AM, Moutal, A, Saloman, JL, Hartnett, KA, Anderson, CT, Tzounopoulos, T, Sun, D, Khanna, R & Aizenman, E 2017, 'Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke', Journal of Neuroscience, vol. 37, no. 23, pp. 5648-5658. https://doi.org/10.1523/JNEUROSCI.3811-16.2017
Yeh, Chung Yang ; Bulas, Ashlyn M. ; Moutal, Aubin ; Saloman, Jami L. ; Hartnett, Karen A. ; Anderson, Charles T. ; Tzounopoulos, Thanos ; Sun, Dandan ; Khanna, Rajesh ; Aizenman, Elias. / Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke. In: Journal of Neuroscience. 2017 ; Vol. 37, No. 23. pp. 5648-5658.
@article{d4957433fb3b47db86d0cb4cdb2b63a1,
title = "Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke",
abstract = "The voltage-gated K+ channel Kv2.1 has been intimately linked with neuronal apoptosis. After ischemic, oxidative, or inflammatory insults, Kv2.1 mediates a pronounced, delayed enhancement of K+ efflux, generating an optimal intracellular environment for caspase and nuclease activity, key components of programmed cell death. This apoptosis-enabling mechanism is initiated via Zn2--dependent dual phosphorylation of Kv2.1, increasing the interaction between the channel’s intracellular C-terminus domain and the SNARE(soluble N-ethylmaleimide-sensitive factor activating protein receptor) protein syntaxin 1A. Subsequently, an upregulation of de novo channel insertion into the plasma membrane leads to the critical enhancement of K+ efflux in damaged neurons. Here, we investigated whether a strategy designed to interfere with the cell death-facilitating properties of Kv2.1, specifically its interaction with syntaxin 1A, could lead to neuroprotection following ischemic injury in vivo. The minimal syntaxin 1A-binding sequence of Kv2.1 C terminus (C1aB) was first identified via a far-Western peptide screen and used to create a protherapeutic product by conjugating C1aB to a cell-penetrating domain. The resulting peptide (TAT-C1aB) suppressed enhanced whole-cell K+ currents produced by a mutated form of Kv2.1 mimicking apoptosis in a mammalian expression system, and protected cortical neurons from slow excitotoxic injury in vitro, without influencing NMDA-induced intracellular calcium responses. Importantly, intraperitoneal administration of TAT-C1aB in mice following transient middle cerebral artery occlusion significantly reduced ischemic stroke damage and improved neurological outcome. These results provide strong evidence that targeting the proapoptotic function of Kv2.1 is an effective and highly promising neuroprotective strategy.",
keywords = "Apoptosis, Ischemia, Neuroprotection, Potassium channel, Syntaxin, Zinc",
author = "Yeh, {Chung Yang} and Bulas, {Ashlyn M.} and Aubin Moutal and Saloman, {Jami L.} and Hartnett, {Karen A.} and Anderson, {Charles T.} and Thanos Tzounopoulos and Dandan Sun and Rajesh Khanna and Elias Aizenman",
year = "2017",
month = "6",
day = "7",
doi = "10.1523/JNEUROSCI.3811-16.2017",
language = "English (US)",
volume = "37",
pages = "5648--5658",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "23",

}

TY - JOUR

T1 - Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke

AU - Yeh, Chung Yang

AU - Bulas, Ashlyn M.

AU - Moutal, Aubin

AU - Saloman, Jami L.

AU - Hartnett, Karen A.

AU - Anderson, Charles T.

AU - Tzounopoulos, Thanos

AU - Sun, Dandan

AU - Khanna, Rajesh

AU - Aizenman, Elias

PY - 2017/6/7

Y1 - 2017/6/7

N2 - The voltage-gated K+ channel Kv2.1 has been intimately linked with neuronal apoptosis. After ischemic, oxidative, or inflammatory insults, Kv2.1 mediates a pronounced, delayed enhancement of K+ efflux, generating an optimal intracellular environment for caspase and nuclease activity, key components of programmed cell death. This apoptosis-enabling mechanism is initiated via Zn2--dependent dual phosphorylation of Kv2.1, increasing the interaction between the channel’s intracellular C-terminus domain and the SNARE(soluble N-ethylmaleimide-sensitive factor activating protein receptor) protein syntaxin 1A. Subsequently, an upregulation of de novo channel insertion into the plasma membrane leads to the critical enhancement of K+ efflux in damaged neurons. Here, we investigated whether a strategy designed to interfere with the cell death-facilitating properties of Kv2.1, specifically its interaction with syntaxin 1A, could lead to neuroprotection following ischemic injury in vivo. The minimal syntaxin 1A-binding sequence of Kv2.1 C terminus (C1aB) was first identified via a far-Western peptide screen and used to create a protherapeutic product by conjugating C1aB to a cell-penetrating domain. The resulting peptide (TAT-C1aB) suppressed enhanced whole-cell K+ currents produced by a mutated form of Kv2.1 mimicking apoptosis in a mammalian expression system, and protected cortical neurons from slow excitotoxic injury in vitro, without influencing NMDA-induced intracellular calcium responses. Importantly, intraperitoneal administration of TAT-C1aB in mice following transient middle cerebral artery occlusion significantly reduced ischemic stroke damage and improved neurological outcome. These results provide strong evidence that targeting the proapoptotic function of Kv2.1 is an effective and highly promising neuroprotective strategy.

AB - The voltage-gated K+ channel Kv2.1 has been intimately linked with neuronal apoptosis. After ischemic, oxidative, or inflammatory insults, Kv2.1 mediates a pronounced, delayed enhancement of K+ efflux, generating an optimal intracellular environment for caspase and nuclease activity, key components of programmed cell death. This apoptosis-enabling mechanism is initiated via Zn2--dependent dual phosphorylation of Kv2.1, increasing the interaction between the channel’s intracellular C-terminus domain and the SNARE(soluble N-ethylmaleimide-sensitive factor activating protein receptor) protein syntaxin 1A. Subsequently, an upregulation of de novo channel insertion into the plasma membrane leads to the critical enhancement of K+ efflux in damaged neurons. Here, we investigated whether a strategy designed to interfere with the cell death-facilitating properties of Kv2.1, specifically its interaction with syntaxin 1A, could lead to neuroprotection following ischemic injury in vivo. The minimal syntaxin 1A-binding sequence of Kv2.1 C terminus (C1aB) was first identified via a far-Western peptide screen and used to create a protherapeutic product by conjugating C1aB to a cell-penetrating domain. The resulting peptide (TAT-C1aB) suppressed enhanced whole-cell K+ currents produced by a mutated form of Kv2.1 mimicking apoptosis in a mammalian expression system, and protected cortical neurons from slow excitotoxic injury in vitro, without influencing NMDA-induced intracellular calcium responses. Importantly, intraperitoneal administration of TAT-C1aB in mice following transient middle cerebral artery occlusion significantly reduced ischemic stroke damage and improved neurological outcome. These results provide strong evidence that targeting the proapoptotic function of Kv2.1 is an effective and highly promising neuroprotective strategy.

KW - Apoptosis

KW - Ischemia

KW - Neuroprotection

KW - Potassium channel

KW - Syntaxin

KW - Zinc

UR - http://www.scopus.com/inward/record.url?scp=85020404245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020404245&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3811-16.2017

DO - 10.1523/JNEUROSCI.3811-16.2017

M3 - Article

C2 - 28483976

AN - SCOPUS:85020404245

VL - 37

SP - 5648

EP - 5658

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 23

ER -